CasLoc logo
All Cases PTAB Litigations UPC Oppositions

OSI Pharmaceuticals LLC v. Roxane Laboratories INC.

1:12-cv-00644

Overview

Case Number 1:12-cv-00644
Filing Date 2012-05-23
Status Terminated
Termination Date 2012-05-24
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Roxane Laboratories Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Genentech Inc Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Pfizer Inc. Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

OSI Pharmaceuticals LLC Operating Company

Represented By

1 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 1 U.S. Courts: 3
USPTO PTAB Trial 2016-06-28
IPR2016-01284

Apotex, Inc. et al. v. OSI Pharmaceuticals, LLC et al.

U.S. Continuation Sibling (6900221)
Status: Final Written Decision
U.S. District Court 2015-09-02
1:15-cv-00772

OSI Pharmaceuticals, LLC v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-12-07
1:12-cv-01669

OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-13
1:12-cv-00465

OSI Pharmaceuticals LLC v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7087613
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
Filed: 2004-11-18
Issued: 2006-08-08
Expired (Term Ended)
Expires: 2024-11-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

1

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MOTION to Dismiss Complaint without prejudice pursuant to F.R.C.P. 41(a)(2) by GENENTECH, INC., OSI PHARMACEUTICALS, LLC, PFIZER, INC.. (DELORENZI, DAVID) [Tran...
Entry #10 • 2012-05-22 Document →

Docket Entries

(17 total)
Pleading / Complaint

COMPLAINT against ROXANE LABORATORIES, INC. (Filing fee $ 350, Receipt # 0312-4308449), filed by OSI PHARMACEUTICALS, LLC, PFIZER, INC., GENENTECH, INC.. (Attachments: # 1 EXH A TO CMP, # 2 EXH B TO CMP, # 3 EXH C TO CMP, # 4 Civil Cover Sheet)(dr, ) (Additional attachment(s) added on 4/25/2012: # 5 Cert 11.2) (dr). Modified on 4/26/2012 (mn). [Transferred from New Jersey on 5/23/2012.] (Entered: 04/24/2012)

Entry #1 • 2012-04-20
1

AO120 Patent/Trademark Form filed. (dr, ) [Transferred from New Jersey on 5/23/2012.] (Entered: 04/24/2012)

Entry #2 • 2012-04-20
1

Corporate Disclosure Statement by PFIZER, INC. identifying NONE as Corporate Parent.. (dr, ) (Main Document 4 replaced on 4/26/2012) (dr). Modified on 4/26/2012 (dr). [Transferred from New Jersey on 5/23/2012.] (Entered: 04/24/2012)

Entry #3 • 2012-04-20
1

Corporate Disclosure Statement by GENENTECH, INC. identifying ROCHE HOLDINGS, INC. as Corporate Parent.. (dr, ) (Main Document 5 replaced on 4/26/2012) (dr). Modified on 4/26/2012 (dr). [Transferred from New Jersey on 5/23/2012.] (Entered: 04/24/2012)

Entry #4 • 2012-04-20
1

Corporate Disclosure Statement by OSI PHARMACEUTICALS, LLC identifying ASTELLAS US LLC as Corporate Parent.. (dr, ) (Main Document 6 replaced on 4/26/2012) (dr). Modified on 4/26/2012 [Transferred from New Jersey on 5/23/2012.] (Entered: 04/24/2012)

Entry #5 • 2012-04-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc